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This study was aimed to investigate the hypocholestrolemic and anti-atherosclerotic properties of 
Tinospora crispa aqueous extract (TCAE) on rabbits for 10 weeks. The hyperlipidemic rabbits were 
induced and the rabbit were given different concentration of TCAE (200, 450 and 600 mg/kg). Results 
from lipid analysis show that the level of total cholesterol (TC), triglyceride (TG) and LDL-C on the 
hyperlipidemic rabbits were reduced with the treatment of TCAE while HDL level was elevated. Through 
plasma analysis, the activity of gamma glutamyl transferase (GGT) and alkaline phosphates (ALP) were 
also reduced with the treatment of TCAE compared to hyperlipidemia group. All group of rabbits tested 
with TCAE again had significantly higher (p < 0.05) total antioxidant status (TAS), glutathione 
peroxidase (GPx) and superoxide dismutase (SOD) activities. Among the concentrations of TCAE 
tested, medium dose showed more potent effect in reducing blood serum TC, TG and LDL-C levels and 
increasing HDL-C level compared to low and high dosages counterparts. No foam cell formation was 
visible in aorta of rabbits treated with TCAE in dose dependent manner. However, there was visible foam 
cell formation in the aorta of hyperlipidemia group. In conclusion, this study suggests that 
supplementation of 450 mg/kg of T. crispa extract would be able to reduce or retard the progression of 
atherosclerotic plaque development induced by dietary cholesterol.  
 





Cardiovascular diseases (CVD) is a world’s largest killer, 
claiming 17.5 million lives a year in 2012, representing 
31% of all global deaths. Of these deaths, an estimated 
7.4 million were due to coronary heart disease and 6.7 
million were due to stroke (WHO, 2015). In Malaysia, 
cardiovascular related diseases contribute to 24.38% of 
reported death in government hospital (MOH, 2014). 
Hyperlipidemia is one of contributing factor for cardiovas-
cular diseases (CVD) such as atherosclerosis, stroke and 





Hyperlipidemia refers to increased level of total 
cholesterol (TC), triglyceride (TG) and low density 
lipoprotein (LDL) as well as decreased level of high 
density lipoprotein (HDL). Reducing blood TC, TG and 
LDL level, while increasing blood HDL level has become 
beneficial factor to overcome CVD, thus evoke many 
investigators to design drugs with the ability to manage 
blood cholesterol level. Among them, statin has become 
the most popular kind of drug that has been produced. 
However, there are many side effects that have been 
reported on this drug consumption including myotoxicity 
and liver disfunction (Sathasivam, 2012). Herbal 
remedies have become popular in recent decades as an 
alternative treatment over modern medicines in the 
screening of hyperlipidemic cure. According to WHO, 
80% of the population in some Asian and African 
countries depend on traditional and herbal medicine for 
primary health care (WHO, 2002). There are several 
studies on the therapeutic effect of herbal extracts on 
various kinds of diseases and ailments including 
diabetes, hypertension and CVD. There are also many 
study performed previously which showed that herbal 
extracts can reduce lipid level on hypercholesterolemia 
rabbit (Berger et al., 2004; Chen et al., 2011; Khanna et 
al., 2002). 
Tinospora crispa, plant locally known as patawali in 
Malaysia is a climber that can be found in primary 
rainforest widely distributed in Malaysia, Indonesia, 
Thailand and Vietnam. To date, several activity of T. 
crispa has been recorded including anti-diabetic (Noor 
and Ashcroft, 1998), hypolipidemia (Praman et al., 2011) 
and anti-inflammatory (Sulaiman et al., 2008). The 
aqueous extract of T. crispa stem can be taken to treat 
diabetes mellitus and improve diabetic conditions (Noor 
and Ashcroft, 1998). Traditionally, this plant was found to 
be used to treat diabetes, hypertension and lumbago 
(Fasihuddin and Hasmah, 1991). The stems of T. crispa 
were commonly used to treat coughs, asthma, fever and 
stomach acnes (Perry, 1980; Muhammad and Mustafa, 
1994). Other than that, it also can be used for purifying 
blood and as preventions against bacterial and viral 
infections (Quisumbing, 1978). Besides, the young stems 
of the plant can be taken raw to reduce high blood 
pressure, diabetes and relieve abdominal pains (Ministry 
of Industry and Primary Resources of Brunei 
Darussalam, 1992). 
Present study sought to investigate the lipid lowering 
properties  of  T. crispa aqueous  extract  (TCAE)  on  the  




hyperlipidemic rabbit model and the parameters of 
hyperlipidemia including TC, TG, LDL and HDL were 
investigated. On the other hand, several biochemical 
parameters that are related to the CVD occurrence such 
as SOD and GPx antioxidant enzyme levels and liver 




MATERIALS AND METHODS 
 
Preparation of T. crispa extract 
 
Fresh stems of T. crispa were collected from Forest Research 
Institute Malaysia (FRIM) at Kepong, Selangor after proven by plant 
taxonomist. The stems were then cut into small pieces of around 2 
inches long followed by drying in the oven at 55°C for 72 h. The 
completely dried stems were then ground into powder by using 
bench-top blender. T. crispa aqueous extract was prepared by 
adding 100 g T. crispa powder to 1000 ml distilled water and 
shaken under shaking water bath at 55°C for 4 h. The solution was 
then filtered and the supernatant was freeze dried at -80°C. The 
finished processed of T. crispa aqueous extract in powder form was 
then store at -20°C until use. 
 
 
Induction of experimental hyperlipidemic rabbits 
 
Forty two (42) male New Zealand White (NZW) rabbits with initial 
mean body weight of 2.5 to 3.0 kg were acclimatized under room 
temperature (28 ± 2°C) with a regular light/dark cycle and free 
access to food and water for 2 weeks before use. Following 
acclimatization, the animals were randomly segregated into six 
groups of seven rabbits each. Normal control (NC) group was given 
normal chow diet while other 5 groups were given 0.5% cholesterol 
chow diet for continuous 10 weeks to induce hyperlipidemic rabbit 
model. Food and water were given ad libitum throughout the 
experiment. Then, the 5 groups were assigned as hyperlipidemia 
group (H), simvastatin group (SC), low dosage (200 mg/kg) of 
TCAE, medium dosage (450 mg/kg) of TCAE and high dosage (600 
mg/kg) of TCAE. The TCAE and simvastatin were given via oral 
gavage while blood sampling was performed 10 weeks of 
experimental period. The experimental protocol and animal 
handling throughout the study were in accordance with guidelines 




Biological sample collection 
 
The animal was sacrificed by exsanguinations for blood and organ 
collection after 12 h of fasting using diethyl ether as anesthetic. 
Approximately 5 mL of blood was collected by cardiac puncture, 
segregated into lithium heparin and EDTA tubes. The bloods 
collected in EDTA tubes were centrifuged at 3000 rpm for 10 min at
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4°C to separate the plasma. The serum was then transferred into 
eppendorf tubes, labeled, covered with aluminium foil and stored at 
-80°C until further analysis. The blood serum was used for 
estimation of lipid profiles, liver toxicity enzymes and total 
antioxidant status (TAS). The bloods collected in heparin tube were 
centrifuged at 3000 rpm for 10 min at 4°C to separate the plasma 
from the erythrocyte. The plasma was then removed and 
erythrocyte was washed with sodium chloride (0.9 w/v NaCl) which 
was centrifuged at 3000 rpm for 10 min at 4°C. The erythrocyte was 
washed with sodium chloride and repeated for three times. Before 





Lipid analysis such as total cholesterol (TC), triglyceride (TG), high 
density lipoprotein-cholesterol (HDL-c) and low density lipoprotein-
cholesterol (LDL-c) in serum were determined by enzymatic 
methods using Rosche commercial kit (Germany) in accordance 
with the manufacturer instruction. All the serums were measured 
using Hitachi Chemistry Analyzer 902 Machine at the Chemistry 
Pathology Laboratory, Faculty of Medicine and Health Sciences, 
University Putra Malaysia.  The test utilizes the principle of 
enzymatic colorimetric assay to read the sample.  
 
 
Antioxidant enzyme test 
 
Antioxidant enzyme activities of glutathione peroxidase GPx, 
superoxide dismutase (SOD) as well as total antioxidant status 
(TAS) were determined in the whole blood using a kit of Randox in 
accordance of manufacturer instruction. All the serums were 
measured using Cobas Mira Plus analyzer at the Research 
Laboratory of Faculty of Medicine and Health Sciences, UPM. 
 
  
Plasma liver function test 
 
The metabolic processes and variety of chemicals that occur in the 
liver were maintained by the help of liver enzymes including 
Alkaline Phospatase (ALP) and Gamma Glutamyl Transpeptidase 
(GGT). In this study, these three enzymes were used to monitor the 
liver toxicity caused by the treatment effect. The level of ALP and 
GGT was measured using Roche commercial kit in accordance with 
the manufacturer instruction. All the serums were measured using 
Hitachi Chemistry Analyzer at the Chemistry Pathology Laboratory, 
Faculty of Medicine and Health Sciences, University Putra 
Malaysia. All enzymes of interest were measured using the 





After the rabbits were killed, aorta tissue between its origin and 
bifurcation into the iliac arteries was taken gently, free of adhering 
tissues and washed with cold normal saline solution. The large part 
of origin was cut into 2 mm3, and was put into 10% formalin for 
haematoxylin and eosin staining, whereas the ascending large part 
of aorta between its origin and bifurcation into the iliac arteries was 
opened longitudinally and prepared for plaque assay.  
 
 
Haematoxylin and eosin staining 
 
The aortic arch were fixed in 10% formalin for a few days and 
prepared for light microscopy by dehydrating the tissue samples in 
an ascending series of alcohol dehydration, clearing with xylene 





tissue processor machine. The tissues were then embedded into 
block by paraffin wax at 62°C and was cooled at 0°C for 3 h to form 
solid block. This is followed by the sectioning process, whereas the 
tissues were trimmed and sectioned with the thickness of 4 to 5 m 
using a microtome machine. The tissues were then placed in the 
water bath, attached on glass slides and then were dried on a hot 
plate at 50 to 55°C for 30 min and then kept at 37°C. The tissues 
sections were then stained with Haematoxylin and Eosin (H&E) 
staining method using Autostainer Machine. The slides underwent 
processing, colorization and dehydration. After thoroughly dried 
from xylene, the slides were mounted with cover slips and mounted 
with DPX. The slides were then dried at room temperature for a few 
days before being analyzed by an Image Analyzer Machine. The 
aortic arch aorta was evaluated quantitatively. 
 
 
Assessment of atherosclerotic plaque lesions 
 
Atherosclerotic plaque areas were assessed by a previously 
described method (Prasad and Kalra, 1993). Briefly, the aortic strips 
were dissected from the ascending arch to the iliac bifurcation, and 
extraneous adipose tissue was removed. The aortas were opened 
longitudinally, rinsed several times with ice-cold saline and 
stretched onto a piece of cardboard. Then, it was fixed immersed in 
neutral 100 g/L buffered formalin solution for 24 h and then rinsed 
in 70% alcohol. The tissue was then immersed in Herxheimer’s 
solution containing Sudan IV (5 g), ethyl alcohol (70%, 500 mL) and 
acetone (500 mL) at room temperature for 15 min and washed in 
running water for 1 h. Photographs of the intimal surface of the 
aorta were taken using digital camera (EOS Canon, Japan) and the 
intimal lipid lesions were determined quantitatively by estimation of 
the percentage of sudanophilic stained areas in the total aortic 
intimal area in photographs using Image Analysis Software. The 
total atherosclerotic area of the intimal surface of the aorta was 
measured in mm2. The extent of atherosclerosis was expressed as 






Statistical analysis for all assays were performed by one-way 
ANOVA with Dunnett’s posthoc multiple group comparison using 
GraphPad Prism software (Version 5). P<0.05 and P<0.01 was 





Hypolipidemic effect of TCAE in hyperlipidemic 
rabbits 
 
Hypolipidemic effect of TCAE and simvastatin are shown 
in Table 1. When compared to control (normal rabbits), 
TC, TG and LDL-C and HDL-C level were markedly 
increased in hyperlipidemic rabbit. After the treatment of 
TCAE at 200, 450 and 600 mg/kg and simvastatin, there 
were significant decrease of TC, TG and LDL-C level in 
serum lipid. TC level of hyperlipidemic rabbits treated 
with low, medium, high dosages of TCAE and simvastatin 
decreased by 35.89, 50.38, 33.94 and 95.03%, 
respectively, compared to untreated hyperlipidemia group 
while TG level of hyperlipidemic rabbits treated with low, 
medium, high dosages of TCAE and simvastatin 
decreased by 73.86, 77.27, 60.23 and 78.98%,




Table 1. Effect of TCAE and simvastatin on the level of TC, TG, LDL-C and HDL-C in 
rabbit blood serum following 10 weeks of treatment. 
 
Treatment group 
Serum lipid profile (mmol/L) (mean ± SD) 




















































Each value represents the mean + SD. Values with the asterisk (*) are significantly 
different (p < 0.05) compared to hyperlipidemia model group in respective test group. 
Values with 
#
 are significantly different (p < 0.05) compared to normal control group in 
respective test group. TC, total cholesterol; TG, triglyceride; LDL-C, low density 
lipoprotein; LDL-C, high density lipoprotein; NC, normal control; H, high cholesterol diet 








NC H Simvastatin 200 450 600 












Each value represents the mean + SD. Values with the asterisk (*) are significantly different (p < 0.05) compared to hyperlipidemia model group. 
Values with 
#
 are significantly different (p < 0.05) compared to normal control group. NC, normal control; H, high cholesterol diet group; TCAE, T. 




respectively, when compared to untreated hyperlipidemia 
group. LDL-C level of hyperlipidemic rabbits treated with 
low, medium, high dosages of TCAE and simvastatin 
decreased by 43.62, 51.12, 39.04 and 94.44%, 
respectively, while LDL-Clevel of hyperlipidemic rabbits 
treated with low, medium, and high dosages of TCAE 
markedly increased by 4.55, 6.22 and 4.67 fold, 




Effect of TCAE on atherosclerotic plaques coverage 
 
Atherosclerotic plaques coverage of hyperlipidemic 
rabbit, treatment group and simvastatin was measured 
using NC as a baseline. Hyperlipidemia rabbit showed 
marked increase of plaques coverage with 31.12 ± 2.18% 
of coverage. TCAE showed marked reduction of 
atherosclerotic plaques coverage when compared to 
hyperlipidemic rabbit and the reduction of plaques area 
was 18.32, 50.87 and 66.25% of reduction for 200, 450 
and 600 mg/kg of TCAE, respectively (Table 2). 
Simvastatin reduced plaques coverage to a greater 
extent with 92.80% of reduction. 
 
 
Effect of TCAE on liver enzymes expression 
 
Effect of  TCAE on liver enzymes expression is shown  in 
Figure 1. Compared to control (normal rabbits), GGT 
expression on hyperlipidemic rabbits significantly 
increased while there was no significant difference in ALP 
expression between hyperlipidemic rabbit and normal 
rabbit. Treatment of TCAE at 200, 450 and 600 mg/kg 
and simvastatin significantly decreased GGT and ALP 
level, when compared to hyperlipidmic rabbit. GGT level 
of hyperlipidemic rabbits treated with low, medium, high 
dosages of TCAE and simvastatin were declined by 
66.63, 77.81, 76.00 and 14.42%, respectively, compared 
to untreated hyperlipidemia group. ALP level of 
hyperlipidemic rabbit treated with low, medium, high 
dosages of TCAE and simvastatin decreased by 76.64, 
89.38, 83.72 and 71.78%, respectively, compared to 
untreated hyperlipidemia group  
 
 
Effect of TCAE on antioxidant enzymes activity and 
total antioxidant status 
 
Effect of TCAE on antioxidant enzymes activity and total 
antioxidant status is shown in Figure 2. Compared to 
those of rabbit in control group (normal rabbits), SOD and 
GPx activity as well as TAS of hyperlipidemic rabbits was 
significantly reduced. Treatment of TCAE at 200, 450 and 
600 mg/kg and simvastatin significantly increased SOD 
and GPx activity as well as TAS when compared to 
hyperlipidmic   rabbits.   SOD  activity   of   hyperlipidemic  


















































































































Figure 1. Effect of TCAE and Simvastatin on the level of A) GGT 
and B) ALP level of all Groups. Each value represents the mean + 
SD. Values with the asterisk (*) are significantly different (p<0.05) 
compared to hyperlipidemia model group in respective test group. 
Values with # are significantly different (p<0.05) compared to 
hyperlipidemia group in respective test group.   GGT, gamma 
glutamyl transpeptidase ; ALP, alkaline phosphatase level; NC, 




rabbits treated with low, medium, high dosages of TCAE 
and simvastatin were increased by 4.22, 7.64, 8.30 and 
1.48 fold, respectively, compared to untreated 
hyperlipidemia group while GPx activity of hyperlipidemic 
rabbits treated with low, medium, high dosages of TCAE 
and simvastatin were increased by 1.65, 1.60, 1.65, 1.87 
and 4.48 fold, respectively, compared to untreated 
hyperlipidemia group. TAS of hyperlipidemic rabbits 
treated with low, medium, high dosages of TCAE and 






Hyperlipidemia is a major pathological basis of CVD such 



































































































































Figure 2. Effect of TCAE and Simvastatin on the level of A) 
SOD level, B) GPx Level and C) TAS of all Groups. Each value 
represents the mean + SD. Values with the asterisk (*) are 
significantly different (p<0.05) compared to hyperlipidemia 
model group. Values with # are significantly different (p<0.05) 
compared to normal control group. SOD, superoxide 
dismutase; GPx, glutathione peroxidase; TAS, total antioxidant 
status; NC, normal control; H, high cholesterol diet group; 





Hyperlipidemia, particularly hypercholesterolemia, can 
increase the risk factor of atherosclerosis by inducing 
arterial endothelial dysfunction (Chen et al., 2011). LDL 
also has been diagnosed to be a major determinant to 
the hypercholesterolemia. Different from LDL, HDL plays 
a role in reverse transport of cholesterol from artery back 
to the liver at which it is eliminated. Therefore, managing 
the elevation of blood LDL, TG, and TC levels are 
important to prevent HL and atherosclerosis, and are of 
great significance in reduction of CVD incidence. Result 
of this study shows that, following a week of 
acclimatization, there were no significant differences in 
blood parameters of all rabbits. However, rabbits fed with 
high cholesterol diet over 10 weeks showed significantly 
higher level of serum TC, TG and LDL-C compared to 
normal diet rabbits. This result showed that the 
hyperlipidemic rabbit model have been established after 
been introduced to high cholesterol diet over 10 weeks 
period. The levels of TC, TG and LDL-C on these 
hyperlipidemic rabbits however, were reduced when it 
was administered to different dosages of TCAE. Among 
the concentrations of TCAE tested, medium dose showed 
more potent effect in reducing blood serum TC and LDL-
C levels compared to low and high dosages counterparts. 
For blood serum TG level, low and medium dosages of 
TCAE exhibit more potent effect to reduce blood serum 
TG level, compared to high dosage of TCAE. In addition 
to that observed result in LDL-C, HDL-C and TC, TCAE 
also reduced the coverage area of atherosclerotic plaque 
compared to hyperlipidemic rabbits group in dose 
dependent manner. It is well known that increased level 
of TC, TG and LDL-C were the major symptom of 
hyperlipidemia. Hyperlipidemia, in turn is a major risk 
factor of atherosclerosis (Nelson, 2013). The decrease of 
TC, TG and LDL-C level of hyperlipidemia group after 
treatment of TCAE have showcase the beneficial effect of 
TCAE consumption in reducing serum cholesterol level 
and these results have been supported by the reduction 
of atherosclerotic plaque coverage of hyperlipidemic 
rabbit that were treated with TCAE. Total cholesterol 
refers to total amount of cholesterol at a given time and 
the sum of LDL-C, HDL-C, very low density lipoprotein 
(VLDL) and intermediate density cholesterol (IDL). In this 
study, TC was significantly increased in hyperlipidemic 
rabbit compared to untreated rabbit. However, TCAE at 
different dosage evidently decrease the TC level and the 
medium dosage of TCAE has again showed the most 
evident effect. 
Gamma glutamyl transferase (GGT) is an enzyme 
which plays a role in extracellular catabolism of 
antioxidant glutathione. It can be found in liver, kidney 
and cerebrovascular endothelium. GGT acts as pro-
oxidant in extra-cellular space. The increase level of GGT 
may be a reflection of high degree of oxidative stress. 
GGT is also found to be positively correlated with 
increase of chronic heart disease events such as 
congestive heart failure and components of the metabolic  




syndrome (Niranjan et al., 2012). Results of GGT test in 
this study shows that TCAE has markedly reduced GGT 
level on hyperlipidemic rabbit. GGT level in rabbit 
administrated with medium and high dosages of TCAE 
decreased by 77.81 and 76.00%, respectively, compared 
to hyperlipidemic rabbits model. Even though low dosage 
of TCAE showed lower inhibitory effect than medium and 
high dosages, it also produced a substantial inhibitory 
effect with 66.63% of inhibition. Alkaline phosphatase 
(ALP), a membrane bound isoenzymes that catalyzes the 
hydrolysis of inorganic pyrophosphate, is expressed in 
variety of tissues including liver and bone, and in lesser 
amounts from intestines, placenta, kidneys, and 
leukocytes (Tonelli et al., 2009). Previous epidemiological 
studies have associated serum ALP levels to increased 
coronary calcification and increased risk of CVD (Adeney 
et al., 2009; Covic et al., 2009; Palmer et al., 2011) and 
the proposed mechanism in which ALP is related to CVD 
may be due to inflammation (Tonelli et al., 2009). In this 
study, medium dosage of TCAE has again showed a 
strong inhibition activity compared to low dosage 
counterpart while it is not significantly different compared 
to high dosage counterpart. The ability of TCAE to inhibit 
the release of GGT and ALP marker demonstrate its 
protective effect from oxidative stress and prevent 
coronary calcification thus decrease the risk of CVD. 
Oxidative stress, apart from hyperlipidemia and liver 
biomarkers, is also an important risk factor for 
atherosclerosis and CVD. Many reported studies has 
shown that oxidative stress cause oxidation of LDL to ox-
LDL and cause endothelial cell injury which lead to 
infiltration of monocyte to the arterial intima and its 
deposition into arterial membrane. Oxidation of LDL to 
ox-LDL is mainly caused by reactive oxygen species 
(ROS), particularly superoxide anion and hydrogen 
peroxide (H2O2) (Liu et al., 2009). Superoxide dismutase 
(SOD) and glutathione peroxidase (GPx) are intracellular 
enzymes that are involved in cellular defence mechanism 
from oxidative stress caused by ROS. SOD plays a role 
in scavenging superoxide anion by forming H2O2 while 
GPx safely decompose H2O2 to water and superoxide 
anion (Yu et al., 2007). In normal circumstances, both 
enzymes can steadily eliminate oxidative stress by 
feedback compensatory mechanism. However, under 
excessive oxidative stress condition caused by 
superoxide anions, or with limited bioavailability of 
endogenous antioxidants, both enzymes were depleted 
and it is reflected by low level of SOD and GPx in 
plasma. In corroboration with that, result of this study 
shows that GPx level in hyperlipidemic rabbits was 
reduced when it was compared to normal rabbit group. 
Rabbits that were treated with TCAE exhibited increased 
level of SOD and GPx compared to hyperlipidemic 
rabbits and even at higher level compared to normal 
group, demonstrating the protective effect of TCAE in 
regulating antioxidant enzymes level under oxidative 
stress circumstance.  




In this case, the increased level of SOD and GPx on 
TCAE-treated rabbits was in dose dependent manner, 
which contradicts the results of the aforementioned 
experiments. This result demonstrates the antioxidant 
capability of TCAE by increasing endogenous antioxidant 





These findings suggest that treatment of TAEC were able 
to positively modulate cholesterol metabolism. 
Supplementation of 450 mg/kg of T. crispa extract would 
be the optimum concentration to reduce or retarde the 
progression of atherosclerotic plaque development 
induced by dietary cholesterol by reducing LDL-C, TC, 
TG, ALP and GGT and raising HDL-C, TAS, GPx and 
SOD. T. crispa may, therefore, be beneficial in preventing 
hypercholesterolemic, atherosclerosis and reducing risk 
factors for coronary artery disease.  
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